We are pleased to announce that the Gland Surgery (GS) has received its 2022 CiteScore: 3, ranking 172 out of 495 journals in the Surgery category.
We are pleased to announce that Gland Surgery (GS) has attained its latest impact factor update for the 2022 citation year: 1.8.
With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.
Welcome to join us at the 18th St. Gallen International Breast Cancer Conference 2023, Vienna, Austria, 15 - 18 March!
The 18th St. Gallen International Breast Cancer Conference 2023 will be held in Vienna, Austria this year during 15-18 March.
We would especially like to express our sincere gratitude to the editorial board members, guest editors, reviewers, authors, and readers for all your support and contributions to GS.
The editorial office of Gland Surgery is pleased to announce that, effective October 2022, Prof. Chen-ping Zhang will become the co-Editor-in-Chief in tandem with Prof. Emad Kandil and Prof. Xi-ru Li.
According to the latest Journal Citation Reports (JCR), GS has attained its latest impact factor update for the 2021 citation year: 2.16.
Beginning in September 2020, Gland Surgery (GS) adopted the Surgery Journal Editors Group (SJEG) joint statement and pledged to "strive for diversity in the peer review process and among the editorial boards and editorial leaders."
We are pleased to announce that Gland Surgery (GS) has attained its latest impact factor update for the 2021 citation year: 2.16.
Greetings from the Editorial Office of GS!
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Gland Surgery (GS) is among the list of COPE membership.
We are pleased to announce to our readers that Gland Surgery (GS) has attained its latest impact factor update for the 2020 citation year: 2.953.
Greetings from the GS Editorial Office! We wish you a happy and fruitful 2021!
In order to meet the increasing demand for gland-focused articles, Gland Surgery (GS) will begin publishing 12 issues per year in January 2021.
According to the latest Journal Citation Reports (JCR), GS has attained its latest impact factor update for the 2019 citation year: 2.190.
We are pleased to announce to our readers that Gland Surgery (GS) has attained its latest impact factor update for the 2019 citation year: 2.190.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.
2019 Annual Report of GS
Application of the CARE Guideline as reporting standard in Gland Surgery
The first Impact Factor for Gland Surgery: 1.922
2018 Annual Report of GS
Gland Surgery is indexed by SCIE: The Best Ending of 2018
Report of Gland Surgery (2017)
GS Annual Report (2016)
AME Publishing Company successfully closed Series A funding of 4 million USD
GS Annual Report (2015)
Join GS in the American College of Surgeons (ACS) Clinical Congress 2015 in Chicago
Gland Surgery, being peer-reviewed and open-accessed since its launch in 2012, is now formally indexed by PubMed Central (PMC), a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM). All articles of Gland Surgery will be searchable in PMC within one month.
The editorial team of Gland Surgery is attending the following conferences in 2014. Your joining us will be warmly welcomed.